SHARE-BASED PAYMENTS

12 Months Ended

Dec. 31, 2022

Share-based Payments

SHARE-BASED PAYMENTS

27.     SHARE-BASED PAYMENTS

Warrants to the placement agent

The Company issued and sold an aggregate of 3,960,000 of its common shares at a price of US$1.85 per share to certain institutional investors on January 22, 2021 through a private placement. In a concurrent private placement, the Company issued the warrants:

(i) to the institutional investors (the “investor warrants”), which gave the right to purchase an aggregate of 1,584,000 common shares of the Company with an exercise price of US$2.35 per share. The investor warrants are exercisable up to three years after January 22, 2021. The Company recognized the investor warrants issued as derivative financial liabilities as the investors have the right to exercise their warrants on a cashless basis according to the agreement clause, please refer to Note 22(b) for further details.

(ii) to the placement agent (the “agent warrants”) as part of placement service fees, which gave the right to purchase an aggregate of 396,000 common shares with an exercise price of US$2.35 per share. The agent warrants are exercisable up to three years after July 21, 2021. There are no cash settlement alternatives. The Group does not have a past practice of cash settlement for the warrants. The Group accounts for the warrants as equity-settled share-based payment.

The fair value of the agent warrants is estimated at the grant date using a binomial option pricing model. The amount was allocated to the issuance of the common shares and the investor warrants according to their fair value at the date of issuance, and CNY1,862 (US$287*) and CNY449 (US$70*) were charged to share capital and administrative expenses respectively.

* As the changes in equity from this private placement transaction are denominated in US$, all the amounts in US$ in this disclosure paragraph are actual transaction amounts and the corresponding amounts in CNY were translated from US$ at the applicable exchange rate on the transaction date, January 22, 2021.

Share options

On July 14, 2022, the Board of Directors of the Company approved to grant option awards for an aggregate of 8,100,000 common shares, without par value, of the Company (the “share options”) to certain individuals under the China Natural Resources, Inc. 2014 Equity Compensation Plan for certain strategic consultant services. The share options vested immediately upon grant and are exercisable up to three years from July 19, 2022. The exercise price for the options is $0.623 per share.

The fair value of the share options is estimated at the grant date using a binomial option pricing model, taking into account the terms and conditions on which the share options were granted. There are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these share options. The Group accounts for share options 2022 as an equity-settled share-based payment and recognize administrative expenses associated with the consultant service reward with a corresponding increase in equity.

(a) Expense arising from share-based payment transactions

The expense recognized during the year for above share-based payments is shown in the following table:

	Year Ended December 31,
	2021		2022		2022
	CNY		CNY		US$
Issuance expense related to agent warrants		447		—		—
Consultants share option expense (Note 6)		—		16,152		2,342
Total		447		16,152		2,342

(b) Movements during the year

The following table illustrates the number of, and movements in, agent warrants during the year:

	Number of shares		Exercise price per share
			US$
Outstanding at January, 2021		—		—
Granted during the year		396,000		2.35
Outstanding as of December 31, 2021		396,000		2.35
		—		—
Outstanding as of December 31, 2022		396,000		0.623	*

The remaining contractual life for the agent warrants as of December 31, 2022 and 2021, were 1.06 years and 2.06 years, respectively. 

* The exercise price was revised to $0.623 per share in July, 2022.

The following table illustrates the number of, and movements in share options during the year:

	Number of shares		Exercise price per share
			US$
Outstanding at January, 2022		—		—
Granted during the year		8,100,000		0.623
Outstanding as of December 31, 2022		8,100,000		0.623

The remaining contractual life for the share option as of December 31, 2022 was 2.53 years.

* The share option numbers above are before giving effect to the Share Combination which became effective on April 3, 2023. Refer to Note 31 for further details.

(c) Inputs to the models

The following tables list the inputs to the models used for agent warrants and share options for the years ended December 31, 2021 and 2022, respectively:

	Agent warrants		Share options
	2021		2022
Fair value at the measurement date (US$)		70		2,400
Fair value at the measurement date (CNY)		449		16,209
Expected volatility (%)		93.67		93.50
Risk-free interest rate (%)		0.19		3.16
Expected life (years)		2.50		3
Share price (US$)		0.901		0.623

The expected life of the agent warrants and share options is based on historical data and current expectations and is not necessarily indicative of exercise patterns that may occur. The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.